PŘEDÁVÁNÍ ÚDAJŮ Sample Clauses

PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, bank account, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Institution acknowledges that the Před i v průběhu Studie může být Hlavní zkoušející a Studijní personál požádán o poskytnutí osobních údajů PSI a (nebo)
Sample 1
AutoNDA by SimpleDocs
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, bank account, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Investigator hereby consents to the processing (including use, disclosure or transfer) of his/her Personal Data by PSI, the Sponsor, their respective agents and affiliates and governmental or regulatory agencies both in the Czech Republic and abroad for the following purposes (the “Purposes”): (a) the conduct of clinical trials; (b) review by governmental or regulatory agencies, PSI, the Sponsor and their agents, and affiliates; (c) satisfying legal or regulatory requirements; and, (d) storage in databases for use in selecting investigators and institutions for future clinical trials. The Investigator also agrees to a transfer of his/her Před i v průběhu Studie může být Hlavní zkoušející a Studijní personál požádán o poskytnutí osobních údajů PSI a (nebo)
Sample 1
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, bank account, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Investigator hereby consents to the processing (including use, disclosure or transfer) of his/her Personal Data by PSI, the Sponsor, their respective agents and Před i v průběhu Studie může být Hlavní zkoušející a Studijní personál požádán o poskytnutí osobních údajů PSI a (nebo)
Sample 1
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, bank account, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Institution acknowledges that the Investigator and the Study Personnel consent to the processing (including use, disclosure or transfer) of his/her Personal Data by PSI, the Sponsor, their respective agents and affiliates and governmental or regulatory agencies both in the Czech Republic and abroad for the following purposes (the “Purposes”): (a) the conduct of clinical trials; (b) review by governmental or regulatory agencies, PSI, the Sponsor and their agents, and affiliates; (c) satisfying legal or regulatory requirements; and, (d) storage in databases for use in selecting investigators and institutions for future clinical trials. The Institution also agrees that the Investigator and the Study Před i v průběhu Studie může být Hlavní zkoušející a Studijní personál požádán o poskytnutí osobních údajů PSI a (nebo)
Sample 1
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the conduct of the Trial the Trial Staff may provide Sponsor and its designee with their personal data (as defined under Applicable Law) (the “Personal Data”). Institution will ensure that all Trial Staff have consented in writing to the processing (including use, disclosure or transfer) of his/her Personal Data by Sponsor and its designee, and their respective agents and affiliates and national and foreign governmental or regulatory agencies for the following purposes (the “Purposes”): (a) the conduct of clinical trials; (b) review by governmental or regulatory agencies, Sponsor and its designees and its and their respective agents, and affiliates; (c) satisfying legal or regulatory requirements; and (d) storage in databases for use in selecting investigators and institutions for future clinical trials; and (e) the transfer of the Personal Data abroad, even if such Personal Data is transferred to countries that do not ensure an equivalent level of protection as in the country where the Trial is taking place. Institution represents and warrants that all Trial Staff have consented to the processing of their Personal Data for the Purposes, including the transfer to other countries not having an equivalent level of protection as the country where the Trial is taking place. Institution will notify Sponsor or its designee immediately in writing if such consent is withdrawn by any Trial Staff. During the course of the Trial and after its completion, Sponsor shall in case of Před zahájením Klinického hodnocení i během jeho provádění mohou Pracovníci klinického hodnocení poskytovat Zadavateli a jeho pověřenému zástupci osobní údaje (definované na základě Platných zákonů) (dále jen „Osobní údaje“). Poskytovatel zajistí, aby Pracovníci klinického hodnocení poskytli souhlas se zpracováním (včetně používání, zpřístupňování a předávání) svých Osobních údajů Zadavatelem a jím pověřenou osobou a jejich příslušnými zástupci a přidruženými subjekty a národními i zahraničními státními či kontrolními úřady pro následující účely (dále jen „Účely“): (a) provádění klinických hodnocení; (b) přezkoumání státními nebo kontrolními orgány, Zadavatelem a jím pověřenými osobami a jejich příslušnými zástupci a přidruženými subjekty; (c) uspokojení zákonných a regulačních požadavků, (d) uložení do databází za účelem využití při výběru zkoušejících a zdravotnických zařízení pro budoucí klinická hodnocení a (e) předávání Osobních údajů do zahraničí, a to i v přípa...
Sample 1
PŘEDÁVÁNÍ ÚDAJŮ. Both prior to and during the course of the Study, the Investigator and the Study Personnel staff may provide PSI and/or the Sponsor with personal data. Such data may include names, contact information, work experience, qualifications, publications, resumés, educational background, performance information, facilities, staff capabilities, and other information relating to the Study (the “Personal Data”). The Investigator hereby consents to the processing (including use, disclosure or transfer) of his/her Personal Data by PSI, the Sponsor, their respective agents and affiliates and governmental or regulatory agencies both in the Czech Republic and abroad for the following purposes (the “Purposes”): (a) the conduct of clinical trials; (b) review by governmental or regulatory agencies, PSI, the Sponsor and their agents, and affiliates;
Sample 1

Related to PŘEDÁVÁNÍ ÚDAJŮ

  • Sample Collection The collection and testing of the samples shall be performed only by a laboratory and by a physician or health care professional qualified and authorized to administer and determine the meaning of any test results. The laboratory performing the test shall be one that is certified by the National Institute of Drug Abuse (NIDA). The laboratory chosen must be agreed to between the Union and the Employer. The laboratory used shall also be one whose procedures are periodically tested by the NIDA where they analyze unknown samples sent to an independent party. The results of employee’s tests shall be made available to the Medical Review Officer. Collection of urine samples shall be conducted in a manner, which provides the highest degree of security for the sample and freedom from adulteration. Recognized strict chain of custody procedures must be followed for all samples as set by NIDA. The Union and the Employer agree that security of the biological urine samples is absolutely necessary therefore the Employer agrees that if the security of the sample is compromised in anyway, any positive test shall be invalid and may not be used for any purpose. Urine samples will be submitted as per NIDA Standards. Employees have the right for Union or legal counsel representative to be present during the submission of the sample. A split sample shall be reserved in all cases for an independent analysis in the event of a positive test result. All samples must be stored in a scientific acceptable preserved manner as established by NIDA. All positive confirmed samples and related paperwork must be retained by the laboratory for at least six (6) months or for the duration of any grievance, disciplinary action or legal proceedings whichever is longer. At the conclusion of this period, the paperwork and specimen shall be destroyed. Tests shall be conducted in a manner to ensure that an employee’s legal drug use and diet does not affect the test results.

  • Hours of Collection Collection of Solid Waste, Recyclable Materials, and Compostable Materials, may occur only within hours authorized by the City. The Municipal Code currently prohibits collection of Solid Waste, Recyclable Materials or Compostable Materials (1) earlier than 6:00 a.m. or later than 6:00 p.m. in residential districts and at schools, churches and commercial premises adjacent to residential districts, and (2) earlier than 4:00 a.m. or later than 9:00 p.m. in commercial districts subject to reasonable modification made by the Director.

  • Dues Deduction 6.2.1 The District shall deduct, in accordance with the CSEA dues and service fee schedule approved by the CSEA delegates, dues from the wages of all employees who are members of CSEA on the date of the execution of this Agreement, and who have submitted dues authorization forms to the District.

  • Fees; Expenses As consideration for the services provided by the Warrant Agent (the “Services”), the Company shall pay to the Warrant Agent the fees set forth on Schedule 1 hereto (the “Fees”). If the Company requests that the Warrant Agent provide additional services not contemplated hereby, the Company shall pay to the Warrant Agent fees for such services at the Warrant Agent’s reasonable and customary rates, such fees to be governed by the terms of a separate agreement to be mutually agreed to and entered into by the Parties at such time (the “Additional Service Fee”; together with the Fees, the “Service Fees”)

  • FEES & CHARGES All points, fees and charges (including finance charges) and whether or not financed, assessed, collected or to be collected in connection with the origination and servicing of each Mortgage Loan have been disclosed in writing to the Mortgagor in accordance with applicable state and federal law and regulation. This representation and warranty is a Deemed Material and Adverse Representation; and

  • Transfer Expenses A transferred employee is expected to make arrangements to move expeditiously but this should not exceed a period of one year from date of transfer, except where there is a specific agreement between the employee and local management for an extension. The employee must provide in writing his/her intention to move to the supervisor, prior to receiving payment for any applicable living expenses. Reimbursement for actual costs incurred in the move will be allowed as follows: • All employees who are eligible for moving expenses shall be afforded 12 weeks from the date the employee reports to work in the new location (i.e., date of transfer) to decide whether or not they wish to move. Payment of the following expenses is predicated on the employee maintaining his/her previous principal residence:

  • CONTRACT AMOUNT Compensation amount(s), when stated in this Bid Specifications, shall not be construed as either the maximum or minimum amount which Department shall be obligated to accept as the result of this Bid Specifications or any Agreement entered into as a result of this Bid Specifications.

  • Dues Deductions 47. Dues deductions, once initiated, shall continue until the authorization is revoked in writing by the employee. For the administrative convenience of the SFMTA and the Association, an employee may only revoke a dues authorization by delivering the notice of revocation to the Controller during the two week period prior to the expiration of this Agreement. The revocation notice shall be delivered to the Controller either in person at the Controller's office or by depositing it in the U.S. Mail addressed to the Payroll/Personnel Services Division, Office of the Controller, Xxx Xxxxx Xxx Xxxx Xxxxxx, 8th Floor, San Francisco, CA 94103; Attention: Dues Deduction. The SFMTA shall deliver a copy of the notices of revocation of dues deductions authorizations to the Association within two (2) weeks of receipt.

  • Costs of Collection In any dispute involving monies owed to Company, the Company shall be entitled to all costs of collection, including reasonable attorney’s fees and interest at 15% per annum or the highest rate allowed by law, whichever is less, unless a lower amount is agreed to by Company.

  • Union Dues Deduction The Company will deduct union dues from new employees who have worked a minimum of forty (40) hours.

Time is Money Join Law Insider Premium to draft better contracts faster.